Nithianandan Selliah

Title: Nithianandan Selliah: Innovator in HIV Treatment

Introduction

Nithianandan Selliah is a notable inventor based in Providence, RI (US). He has made significant contributions to the field of medical science, particularly in the treatment of HIV. His innovative approach focuses on the development of chimeric immune T-cell receptors, which have the potential to revolutionize HIV therapy.

Latest Patents

Nithianandan Selliah holds 1 patent for his invention titled "Methods and compositions for treating HIV." This patent features nucleic acid constructs encoding chimeric immune T-cell receptors (CIRs) that are useful for treating HIV in patients. The CIRs are designed with an extracellular domain that targets HIV or HIV-infected cells, a transmembrane domain, and a cytoplasmic domain for mediating T-cell activation. This innovative method also includes the use of host cells expressing CIRs in the treatment of HIV.

Career Highlights

Throughout his career, Nithianandan Selliah has worked with reputable organizations such as Prospect Chartercare, LLC and Roger Williams Medical Center. His experience in these institutions has allowed him to collaborate with other professionals in the field and contribute to advancements in medical research.

Collaborations

One of his notable collaborators is Richard P Junghans. Their partnership has likely fostered innovative ideas and research in the realm of HIV treatment.

Conclusion

Nithianandan Selliah's work in developing methods for treating HIV showcases his dedication to improving patient outcomes through innovative science. His contributions to the field are significant and reflect the ongoing efforts to combat this global health challenge.